How A Swiss Company Spent $15 Million To Get A Controversial Enzyme Into America’s Corn Crop (SYT)
The USDA recently approved a form of industrial corn that terrifies the North American Miller’s Association, who warn that contamination would have “significant adverse impacts.”
Why did Enogen, which is used for ethanol production, get approval?
The answer has something to do with the surge in lobbying activity from Swiss biotech firm Syngenta, during which they created campaign funding relationships with almost every high-ranking agricultural official in Congress.
From 2000 to 2010, Syngenta spent a remarkable $15.4 million on campaign contributions through its PAC and both direct and third party lobbying activities.
Click here to see Syngenta’s lobbying trail >
Click here to learn more about Enogen >
Syngenta was created out of divisions sold off by Novartis and Astra Zeneca
The two pharmaceutical giants sold off their agribusiness divisions, which then merged into Syngenta, incorporating in Switzerland during the year 2000.
By taking on…
Related Posts
